Adel Kardosh

12PUBLICATIONS
66CO-AUTHORS
Cancer diagnosisHaematological tumoursMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 01, 2026
Cyclic immunofluorescence platform using photocleavable linkers for direct antibody labeling enables cancer phenotyping.

|Jul 13, 2026
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial.

|Jan 05, 2026
Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types.

Ya-Mei Hu, Faming Zhao, Julie N Graff

|Nov 09, 2024
Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer.

Ranish K Patel, Michael Parappilly, Hannah C Farley

|Oct 08, 2024
CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer.

Charles D Lopez, Adel Kardosh, Emerson Y Chen

|Sep 14, 2024
Exploratory Analyses of Circulating Neoplastic-Immune Hybrid Cells as Prognostic Biomarkers in Advanced Intrahepatic Cholangiocarcinoma.

Ranish K Patel, Michael S Parappilly, Brett S Walker

Pageof 2

Frequent Collaborators

3 joint publications

Melissa H Wong

3 joint publications

Gordon B Mills

3 joint publications

Shaun M Goodyear

2 joint publications

Emerson Y Chen